advertisement
Abstract #47751 Published in IGR 13-4
Phaco-deep sclerectomy with mitomycin C versus phaco-trabeculectomy in patients with coexisting cataract and glaucoma
Razek AA; Shalaby AA; Maaly ESA; Elazhary YEBiosciences Biotechnology Research Asia 2011; 8: 59-66
Purpose: To compare the outcomes of phaco-deep sclerectomy (P-DS) augmented with mitomycin C with phaco-trabeculectomy (P-T) principally regarding the effect on the intraocular pressure (IOP). Methods: Fifty eyes of thirty-eight patients diagnosed with senile cataract and primary open angle glaucoma were divided into two equal groups. Group A underwent Phaco-deep sclerectomy (PDS) with mitomycin C (MMC) while group B underwent phaco-trabeculectomy (PT). Postoperative IOP was followed up for six months. Results: By the end of the sixth month complete success (IOP < 21 mmHg without anti-glaucoma therapy) was achieved in 80% in group A and 84% in group B. By the end of the sixth month qualified or partial success (IOP < 21 mmHg with anti-glaucoma therapy) was achieved in 12% in both groups A and B. Conclusion: P-DS with MMC does not exceed conventional P-T in what concerns IOP reduction. However the complication rate is lower in P-DS. Augmentation of PDS with MMC is safe with few serious complications related to its use and MMC augmentation appears to increase the probability of achieving lower target intraocular pressures after combined P-DS.
A.A. Razek. Department of Ophthalmology, Zagazig University, M.D., Zagazig - 44519, Egypt.
Classification:
12.14.3 Phacoemulsification (Part of: 12 Surgical treatment > 12.14 Combined cataract extraction and glaucoma surgery)
12.8.10 Woundhealing antifibrosis (Part of: 12 Surgical treatment > 12.8 Filtering surgery)
